Differential Diagnosis of Benign and Cancer Prostate The detection of Hexim1 gene expression levels by polymerase chain reaction (PCR) complemented by analysis of tissue and cellular distribution using immunohistocheistry (IHC) will provide critical information not only in the growth status of the prostate gland but more importantly, it will distinguish between benign or cancerous growth. It will be a... Category(s): Technology Classifications > Diagnostics, Technology Classifications > Gene Therapy, Campus > SUNY Old Westbury

Diagnosis and Treatment of Prostate Cancer HEXIM 1 (hexamethylene bisacetamide inducible protein 1) is an intracellular phosphoprotein which plays regulatory roles in gene transcription and cell cycle signaling pathways. This technology comprises the measurement of HEXIM1 expression, phosphorylation state and/or subcellular localization to monitor, diagnose and prognose stages of prostate cancer.... Category(s): Technology Classifications > Diagnostics